Axsome Therapeutics AXSM Business Segments
| FY'24 | FY'23 | ||
|---|---|---|---|
| Revenue by Product | |||
| Royalty And Milestone Revenue | $4.02M+67.0% | $2.41M— | |
| Royalty | $3.08M+27.9% | $2.41M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Axsome Therapeutics break its business down?
- Axsome Therapeutics (AXSM) reports revenue by product across 3 parts — Milestone Revenue, Royalty And Milestone Revenue and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Axsome Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Axsome Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
